Dublin Core
Title
70 Years of Levothyroxine
Subject
Pharmacology
Description
This open access book presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment. This book is intended for healthcare professionals.
Creator
Kahaly, George J. (editor)
Source
https://library.oapen.org/handle/20.500.12657/47292
Publisher
Publisher Springer Nature
Publisher website https://www.springernature.com/gp/products/books
Rights
https://creativecommons.org/licenses/by/4.0/
Format
PDF
Language
English
Type
Textbook
Identifier
DOI 10.1007/978-3-030-63277-9
ISBN 9783030632779, 9783030632779